SEC Form 4 · accession 0001209191-15-084774
TREVENA INC · TRVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Soergel
Officer — Sr. VP,Clinical Dev. & CMO
Period of report
Dec 10, 2015
Accepted (ET)
Dec 11, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429560
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 10, 2015 | S | 27,217 | $10.55 | D | 1,750 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 23, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in several transactions at prices ranging from $10.13 - $10.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.